Ke Jing, Cao Minghua, Zhang Wenzhong, Huang Hua, Chen Ping, Liu Jinhua, Shan Dan, Ke Jie, Wang Zerui, Liu Junchen, Li Yuan, Xiao Sheng
Department of Thyroid and Breast Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Department of Thyroid and Breast Surgery, The First People's Hospital of Jiashan County, Jianxing, China.
Front Oncol. 2024 May 28;14:1332522. doi: 10.3389/fonc.2024.1332522. eCollection 2024.
Rearrangements involving the neurotrophic-tropomyosin receptor kinase (NTRK) gene family (, and ) have been identified as drivers in a wide variety of human cancers. However, the association between rearranged thyroid carcinoma and clinicopathological characteristics has not yet been established. In our study, we retrospectively reviewed medical records of thyroid cancer patients and identified 2 cases with rearrangement, no additional molecular alterations were observed in either of these cases. The fusion of the rearrangement in both cases was (E4)::(E14). By analyzing the clinicopathological features of these two cases, we found that both were characterized by multiple tumor nodules, invasive growth, and central lymph node metastases, indicating the follicular subtype of papillary thyroid carcinoma. Immunohistochemical staining profiles showed CD56-, CK19+, Galectin-3+, HBME1+. These clinicopathological features suggest the possibility of rearranged thyroid carcinoma and highlight the importance of performing gene fusion testing by FISH or NGS for these patients.
涉及神经营养性原肌球蛋白受体激酶(NTRK)基因家族( 、 和 )的重排已被确定为多种人类癌症的驱动因素。然而,重排型甲状腺癌与临床病理特征之间的关联尚未确立。在我们的研究中,我们回顾性地查阅了甲状腺癌患者的病历,确定了2例发生 重排的病例,这两例均未观察到其他分子改变。两例中 重排的融合形式均为(E4)::(E14)。通过分析这两例病例的临床病理特征,我们发现二者均具有多个肿瘤结节、浸润性生长和中央淋巴结转移的特点,提示为甲状腺乳头状癌的滤泡亚型。免疫组化染色结果显示CD56阴性、CK19阳性、Galectin-3阳性、HBME1阳性。这些临床病理特征提示了重排型甲状腺癌的可能性,并突出了对这些患者进行荧光原位杂交(FISH)或二代测序(NGS)基因融合检测的重要性。